Clinical Trial Update: Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant [Phase 2]

View source ↗

Summary

Phase II clinical trial in elderly patients with acute myeloid leukemia or myelodysplastic syndromes in complete remission not eligible for allogeneic transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Ciceri Fabio | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED